Sanofi, a global leader in healthcare - Sanofi

Committed to Hemophilia Research

Committed to Hemophilia Research

Read the article

Woman standing up

From Acceptance to Advocacy: Megan’s Fabry Disease Journey

Read the article

Facing Down the World’s Deadliest Animal

Read the article

Talkinghearts campaign

Discover Sanofi’s daily commitment to your health

Financial Results

Sanofi delivered solid growth in second quarter 2019 results

Access the results

Press releases
2019-08-06MMMM DD YYYY
Sanofi : Dupixent® (dupilumab) showed positive topline results in Phase 3 trial of children aged 6 to 11 years with severe atopic dermatitis
Read more

Many pills in a box

Preparing to Travel? Protect Yourself and Your Family from Falsified Medicines

What is a Falsified Medicine?

Read the article

What Are The Risks For Me And My Family?

Read the article

Sanofi’s Commitment to Better Health For All

Read the article